The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database.
Ankylosing spondylitis
Epidemiology study
Incidence
Prevalence
Spondyloarthritis
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
received:
15
04
2024
accepted:
15
07
2024
medline:
24
7
2024
pubmed:
24
7
2024
entrez:
23
7
2024
Statut:
epublish
Résumé
Ankylosing spondylitis (AS), an inflammatory condition affecting axial and peripheral joints, exhibits varying prevalence worldwide. This study sought to ascertain AS incidence and prevalence in Thailand from 2017 to 2020. Utilizing national databases, individuals aged 18 and above with primary AS diagnoses (ICD-10 code M45) were identified. AS prevalence and incidence were calculated with 95% confidence intervals. The total number of AS patients was 13,292 patients in 2017. The prevalence of AS was 20.4 per 100,000 populations (95% CI 20.0-20.7) in 2017. The number of new AS cases, identified during 2018-2020, was 6784, 6805, and 6791 patients, respectively. The incidences of AS in 2018, 2019, and 2020 were comparable with the incidence of 10.4 (95% CI 10.1-10.6) per 100,000-person-years. The peak age at diagnosis was 50-59 years of age between 2018 and 2020. The number of female patients was 57.8%, 57.0%, and 57.6%, in 2018, 2019, and 2020, respectively. In conclusion, AS was relatively rare among Thais and comparable between males and females. The prevalence and incidence of AS in Thailand were identified by the Thailand Database Ministry of Public Health. The epidemiological profile of AS in Thailand might help to plan better care, workforce needs, and public health budgets.
Identifiants
pubmed: 39043752
doi: 10.1038/s41598-024-67666-7
pii: 10.1038/s41598-024-67666-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16981Informations de copyright
© 2024. The Author(s).
Références
Zhu, W. et al. Ankylosing spondylitis: Etiology, pathogenesis, and treatments. Bone Res. 7, 22. https://doi.org/10.1038/s41413-019-0057-8 (2019).
doi: 10.1038/s41413-019-0057-8
pubmed: 31666997
pmcid: 6804882
Braun, J. & Sieper, J. Ankylosing spondylitis. Lancet 369(9570), 1379–1390. https://doi.org/10.1016/S0140-6736(07)60635-7 (2007) (PMID: 17448825).
doi: 10.1016/S0140-6736(07)60635-7
pubmed: 17448825
Akkoc, N. Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review. Curr. Rheumatol. Rep. 10(5), 371–378 (2008).
doi: 10.1007/s11926-008-0060-3
pubmed: 18817640
Chaiamnuay, P., Darmawan, J., Muirden, K. D. & Assawatanabodee, P. Epidemiology of rheumatic disease in rural Thailand: A WHO-ILAR COPCORD study. Community oriented programme for the control of rheumatic disease. J. Rheumatol. 25, 1382–1387 (1998).
pubmed: 9676773
Reveille, J. D. Epidemiology of spondyloarthritis in North America. Am. J. Med. Sci. 341, 284–286. https://doi.org/10.1097/maj.0b013e31820f8c99 (2011).
doi: 10.1097/maj.0b013e31820f8c99
pubmed: 21430444
pmcid: 3063892
Dean, L. E. et al. Global prevalence of ankylosing spondylitis. Rheumatology 53, 650–657. https://doi.org/10.1093/rheumatology/ket387 (2014).
doi: 10.1093/rheumatology/ket387
pubmed: 24324212
Zhao, J. et al. Prevalence of ankylosing spondylitis in a Chinese population: A systematic review and meta-analysis. Rheumatology International 40, 859–872 (2020).
doi: 10.1007/s00296-020-04537-0
pubmed: 32125505
Zhao, J. et al. Prevalence of ankylosing spondylitis in a Chinese population: A systematic review and meta-analysis. Rheumatol. Int. 40(6), 859–872 (2020).
doi: 10.1007/s00296-020-04537-0
pubmed: 32125505
Śliwczyński, A. et al. Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system. Rheumatol. Int. 35, 1361–1367 (2015).
doi: 10.1007/s00296-015-3247-8
pubmed: 25773659
Zhao, S. S., Pittam, B., Harrison, N., Ahmed, A. E. & Goodson, N. J. Diagnostic delay in axial spondyloarthritis: A systematic review and meta-analysis. Rheumatology 59(3), 686–696 (2020).
Hwang, M. C., Ridley, L. & Reveille, J. D. Ankylosing spondylitis risk factors: A systematic literature review. Clin. Rheumatol. 40(8), 3079–3093. https://doi.org/10.1007/s10067-021-05679-7 (2021).
doi: 10.1007/s10067-021-05679-7
pubmed: 33754220
pmcid: 9044547
Crossfield, S. S., Marzo-Ortega, H., Kingsbury, S. R., Pujades-Rodriguez, M. & Conaghan, P. G. Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades. RMD Open 7(3), e001888 (2021).
doi: 10.1136/rmdopen-2021-001888
pubmed: 34887345
pmcid: 8663075
Haroon, N. N., Paterson, J. M., Li, P. & Haroon, N. Increasing proportion of female patients with ankylosing spondylitis: A population-based study of trends in the incidence and prevalence of AS. BMJ Open. 4(12), e006634. https://doi.org/10.1136/bmjopen-2014-006634 (2014).
doi: 10.1136/bmjopen-2014-006634
pubmed: 25510888
pmcid: 4267076
Walsh, J., Hunter, T., Schroeder, K., Sandoval, D. & Bolce, R. Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006–2016. BMC Rheumatol. 23(3), 39. https://doi.org/10.1186/s41927-019-0086-3 (2019).
doi: 10.1186/s41927-019-0086-3